Exhibit 10.46 SPONSORED RESEARCH AGREEMENT ---------------------------- THIS AGREEMENT is made as of July 1, 2006 by and between Beth Israel Deaconess Medical Center, Inc., a Massachusetts nonprofit corporation, having its principal place of business...Sponsored Research Agreement • July 7th, 2006 • Dnaprint Genomics Inc • Services-commercial physical & biological research • Massachusetts
SPONSORED RESEARCH AGREEMENT NO. UTAUS-FA________Sponsored Research Agreement • January 25th, 2022
This Sponsored Research Agreement (“Agreement”) is made by and between The University of Texas at Austin, Austin, Texas (“University”), an institution of higher education created by the Constitution and laws of the State of Texas under The University of Texas System (“System”), and ________________, a _____________ corporation with its principal place of business at ___________________________________________ (“Sponsor”). University and Sponsor shall be referred to herein individually as a “Party” and collectively as the “Parties.”.
SPONSORED RESEARCH AGREEMENT Fixed PriceSponsored Research Agreement • May 23rd, 2022 • Texas
This Sponsored Research Agreement (the "Agreement") is made between The University of Texas at San Antonio, ("University"), an academic component of The University of Texas System ("System"), having an address at One UTSA Circle, San Antonio, Texas 78249, and ____________, a corporation with a principal place of business at __________ ("Sponsor").
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • November 1st, 2018 • Arizona
This Sponsored Research Agreement (“Agreement”) is entered into on this date, , , 20 by and between the Arizona Board of Regents for and on behalf of Northern Arizona University, a public land grant university with its principal place of business 1395 S. Knoles Drive, Flagstaff, AZ 86011-4087, (“NAU”) or (“University”) and
Sponsored Research AgreementSponsored Research Agreement • March 14th, 2024 • Illinois
This Sponsored Research Agreement (“Agreement”) is between THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, a body corporate and politic organized and existing under the laws of the State of Illinois, on behalf of the University of Illinois Urbana-Champaign, through Sponsored Programs Administration, 1901 South First Street, Suite A, Champaign IL 61820-7406 (“UNIVERSITY”), and , organized and existing under the laws of with its principal offices at (“SPONSOR”). The parties may be referred to individually as “Party” and collectively as the “Parties”.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • October 21st, 2020
THIS SPONSORED RESEARCH AGREEMENT (this “Agreement”) is made and entered into effective as of [MONTH] [DAY], [YEAR] by and between KEIO UNIVERSITY, having its principal place of business at 2-15-45 Mita, Minato-ku, Tokyo 108-8345, Japan (“University”), and [NAME OF COUNTERPARTY], having its principal place of business at [ADDRESS] (the “Company”). Each of University and Company may be referred to herein individually as a “Party” or collectively as the “Parties.”
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • December 16th, 2021 • Wisconsin
This Fixed-Price Sponsored Research Agreement (the "Agreement") is entered into by the Board of Regents of the University of Wisconsin System on behalf of the University of Wisconsin-Milwaukee (the “University") and ___________________ (the “Sponsor"), each as “Party” and collectively as “Parties”.
R E C I T A L S ---------------Sponsored Research Agreement • July 21st, 2006 • Cytodyn Inc • Pharmaceutical preparations • Massachusetts
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • May 5th, 2020 • Pennsylvania
THIS SPONSORED RESEARCH AGREEMENT (the “Agreement”), effective as of the ___ day of ___________, 200_ (the “Effective Date”), is by and between _________________ [Company Name] a __________ [Company’s state of incorporation] business corporation (hereinafter referred to as "Sponsor") and LEHIGH UNIVERSITY, a Pennsylvania non-profit corporation (hereinafter referred to as "University").
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • September 16th, 2020 • California
This Research Agreement is entered into as of ___________________ (the “Effective Date”) by and between _____________________________, a ________________________ (“Sponsor”) and the University of Southern California, a California non-profit public benefit corporation (“USC”).
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • May 13th, 2022 • Illinois
This Agreement is made by and between Northwestern University, an Illinois non-profit educational and research corporation having its business address at 633 Clark Street, Evanston, Illinois, 60208-1110 (hereinafter “Northwestern”) and ______________, having its business address at ____________________ (hereinafter “Sponsor”).
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • September 30th, 2019 • Cabaletta Bio, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This Sponsored Research Agreement (“Agreement”) is dated as of April 23, 2018 (the “Effective Date”) by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), with offices located at Penn Center for Innovation, [****], and Tycho Therapeutics, Inc., a Delaware corporation (“Sponsor”), having a place of business at 501 Northwick Lane, Villanova, PA 19085. Penn and Sponsor may be referred to herein as a “Party” or, collectively, as “Parties”.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • July 29th, 2016 • Pennsylvania
THIS AGREEMENT, effective this day of , 20 _, by and between The Pennsylvania State University (hereinafter referred to as "University") and , having a principal place of business at:
Sponsored Research AgreementSponsored Research Agreement • April 1st, 2021 • Texas
This Sponsored Research Agreement (“Agreement”) is between the University of Houston, (“UH”) an agency of the State of Texas pursuant to Chapter 111, Texas Education Code, and , a existing under the laws of (“Sponsor”) having its principal office at . The signatories to this Agreement shall be collectively referred to as the “Parties” and individually as a “Party”, as applicable.
Sponsored RESEARCH AGREEMENTSponsored Research Agreement • April 23rd, 2021 • California
This Agreement is between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an institution of higher education having corporate powers under the laws of the State of California, and COMPANY INC. (“Company”), a corporation having a principal place of business at ______________________________________________.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • August 9th, 2023
This Sponsored Research Agreement (the “Agreement”) made and effective as of (the “Effective Date”) is entered into by and between (hereinafter, “Sponsor”) with a principal place of business at and The University of Toledo, a public institution of higher education of the State of Ohio (hereinafter, “University”) with a principal place of business at 2801 W. Bancroft St., Toledo, Ohio 43606-3390, individually, a “Party” and collectively, the “Parties”.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • April 23rd, 2021 • Ohio
This Sponsored Research Agreement (“the Agreement”), effective as of the __ day of ____, 20__ (the “Effective Date”), is between ________ [Name of Sponsor in Bold Type] (“Sponsor”), and Case Western Reserve University (the “University”). The University and Sponsor desire to undertake and support a research program that will further the University’s educational and research purposes in a manner consistent with the University’s nonprofit, tax exempt, status, and will address the Sponsor’s objectives. To accomplish this, the University and the Sponsor agree as follows:
Sponsored Research AgreementSponsored Research Agreement • May 5th, 2020 • Texas
This Sponsored Research Agreement (“Agreement”) is between the University of Houston-Downtown, (“UHD”) an agency of the State of Texas pursuant to Chapter 111, Texas Education Code, and , a existing under the laws of the State of (“Sponsor”) having its principal office at . The signatories to this Agreement shall be collectively referred to as the “Parties” and individually as a “Party”, as applicable.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • May 20th, 2023 • Georgia
This Research Project Agreement (the “Agreement”) entered into as of this ___ day of ___________2009 (the “Effective Date”) by and between Emory University, with offices located at 1599 Clifton Road NE, 4th Floor, Mailstop 1599-001-1BA, Atlanta, GA 30322 (“Emory”) and (NAME OF SPONSOR AND ADDRESS) (“SPONSOR”) (each a “Party” and collectively the “Parties”)
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • September 14th, 2018 • Arvinas Holding Company, LLC • Pharmaceutical preparations • New York
THIS SPONSORED RESEARCH AGREEMENT (this “Agreement”) dated as of March 7, 2018 (the “Effective Date”), is entered into between The Silverstein Foundation For Parkinson’s With GBA, a Delaware corporation (the “TSF”) and Arvinas, Inc., a Delaware corporation (“Company”), having a place of business located at 5 Science Park, New Haven, CT 06511.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • April 8th, 2023 • Ontario
This Sponsored Research Agreement (the “Agreement”, as further defined below) is made as of [Insert date] (the “Effective Date”) and is between the following parties:
Exhibit D SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • August 24th, 2018 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • New York
This Sponsored Research Agreement (this “Agreement”), effective as of the date of the signature of the underlying license agreement, SK2017-1696, dated November 13, 2017, (“Effective Date”), is between Memorial Sloan Kettering Cancer Center, a New York not-for-profit entity, with offices at 1275 York Avenue, New York, NY 10065 (“MSK”) and Y-mAbs Therapeutics, Inc., a Delaware corporation with a principal office at 750 3rd Avenue. New York, N.Y. 10017 (“Sponsor”). MSK and Sponsor may be individually referred to as a “Party”, and collectively as the “Parties”. This Exhibit D, including Appendix A and Appendix B attached hereto, replaces the Exhibit D (including Appendix B) of the License Agreement for MSK’s technology “CD33 Antibodies and constructs thereof” between Memorial Sloan Kettering Cancer Center and Y-mAbs Therapeutics, Inc., dated November 10, 2017 in its entirety, and such original Exhibit D is hereby cancelled and void.
EX-10.2 3 edit-20180630ex102f1598a.htm EX-10.2 EXECUTION VERSION Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. Sponsored Research AgreementSponsored Research Agreement • May 5th, 2020 • Massachusetts
This Sponsored Research Agreement (this “Agreement”), dated as of June 7, 2018 (the “Effective Date”), is made by and between the Broad Institute, Inc. (“Broad”), a non-profit Massachusetts corporation, with a principal office at 415 Main Street, Cambridge, MA 02142, and Editas Medicine, Inc. (“Company”), a Delaware corporation, with a principal office at 11 Hurley Street, Cambridge, Massachusetts 02141. Each of Broad and Company may be referred to herein as a “Party” or together as the “Parties.”
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • December 30th, 2014 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments
This Sponsored Research Agreement (“Agreement”), effective as of the 25 day of April, 2014 (the “Effective Date”) is made by and between The University of Texas M. D. Anderson Cancer Center, (“MD Anderson” or “MDACC”), a member institution of The University of Texas System (“System”), with a place of business at 1515 Holcombe Blvd., Houston, Texas, 77030, and HTG Molecular Diagnostics, Inc., a Delaware corporation with a place of business at 3430 E. Global Loop, Tucson, AZ 85706 (“Sponsor” or “HTG”). MD Anderson and Sponsor hereinafter may be referred to each as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • May 27th, 2010 • Med BioGene Inc. • Services-medical laboratories • Ontario
This amended and restated agreement (this “Agreement”) is made effective as of the 14th day of April 2008 (the “Effective Date”) and is amended as of the 24th day of February 2009 (the “Amendment Date”) between:
Sponsored Research Agreement SummarySponsored Research Agreement • June 15th, 2022 • Massachusetts
A Sponsored Research Agreement (Agreement) is a contract between a university or other research Institution (Institution) and a company (Sponsor) that wants to conduct research in the Institution’s lab. Below is a high-level summary of the agreement intended to help introduce the document to readers. The summary is purely for informational purposes and should not be construed as legal advice for any particular facts or circumstances.
First Amendment to the Sponsored Research AgreementSponsored Research Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • Pennsylvania
This FIRST AMENDMENT TO THE SPONSORED RESEARCH AGREEMENT (the "First Amendment") is made as of the date of the last signature below (the "First Amendment Effective Date"), by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a Pennsylvania nonprofit corporation located at 3601 Spruce Street, Philadelphia, PA 19104 ("Wistar"), and ONCOCYTE CORPORATION, a corporation organized under the laws of California, with a principal place of business located at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("Sponsor"). Wistar and Sponsor shall be referred to herein individually as a "Party" and collectively as the "Parties."
EXCLUSIVE LICENSE AGREEMENTSponsored Research Agreement • October 14th, 2011 • Ceres, Inc. • Agricultural production-crops
This Exclusive License Agreement (Agreement), effective as of this day of November 1, 2001 (the “Effective Date”), is by and between Cambridge University Technical Services Ltd., an English limited company (“CUTS”) and Ceres, Inc. (“Ceres”), a Delaware corporation, having a principal place of business at 3007 Malibu Canyon Road, Malibu, California 90265.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • November 9th, 2021 • Oklahoma
This Agreement entered into on this day of , 20 (“Effective Date”), by and between Oklahoma State University, an institute of higher education of the State of Oklahoma, hereinafter referred to as "University," and , a corporation duly organized under the laws of the State of and having a principal place of business at , hereinafter referred to as "Sponsor."
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • August 24th, 2018 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • New York
This Sponsored Research Agreement (this “Agreement”), effective as of the date of the last signature below (“Effective Date”), is between Memorial Sloan Kettering Cancer Center, a New York not-for-profit entity, with offices at 1275 York Avenue, New York, NY 10065 (“MSK”) and YmAbs, a Delaware corporation with a principal office at 750 Third Avenue, New York, NY 1017,(“Sponsor”). MSK and Sponsor may be individually referred to as a “Party”, and collectively as the “Parties”.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • December 5th, 2013 • Retrophin, Inc. • Pharmaceutical preparations
This Sponsored Research Agreement ("Agreement"), effective as of this 1st day of October 2013 ("Effective Date"), is entered into by and between St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105 ("St. Jude") and Retrophin, Inc., a Delaware Corporation located at 777 Third Avenue, 22nd Floor, New York, New York 10017 ("Sponsor" and collectively with St. Jude, the “Parties”),
Fixed Price Agreement Number:Sponsored Research Agreement • May 5th, 2020 • Texas
This Sponsored Research Agreement (the “Agreement”) is made between (insert name and address of sponsor) (“Sponsor”) and The University of Texas at Arlington, 701 Nedderman, Box 19145, Arlington, Texas 76019-0145 (“University”), a State Institution of Higher Education established under the laws of the State of Texas as an institution of The University of Texas System (“System”).
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • June 19th, 2019 • Cell Source, Inc. • Pharmaceutical preparations • Texas
This Sponsored Research Agreement (“Agreement”), effective as of the 28th day of November, 2018 (the “Effective Date”) is made by and between The University of Texas M. D. Anderson Cancer Center, (“MD Anderson”), a member institution of The University of Texas System (“System”), with a place of business at 1515 Holcombe Blvd., Houston, Texas, 77030, and Cell Source, a corporation with a place of business at 57 West 57th Street, Suite 400, New York, NY 10019. (“Sponsor”). MD Anderson and Sponsor hereinafter may be referred to each as a “Party” and collectively as the “Parties.”
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • June 13th, 2011 • Texas
This Sponsored Research Agreement (the "Agreement") is made between The University of Texas , ("University"), a component institution of The University of Texas System ("System"), and , a corporation with its principal place of business at ("Sponsor").
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • November 23rd, 2015 • OncoCyte Corp • In vitro & in vivo diagnostic substances • Pennsylvania
This SPONSORED RESEARCH AGREEMENT (the "Agreement") is made as of the 13th day of September, 2013 (the "Effective Date") by and between THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, a Pennsylvania nonprofit corporation located at 3601 Spruce Street, Philadelphia, PA 19104 ("Wistar"), and ONCOCYTE CORPORATION, a corporation organized under the laws of California, with a principal place of business located at 1301 Harbor Bay Parkway, Alameda, CA 94502 ("Sponsor").
